We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.6B
AUM Growth
+$1.35B
(+9.5%)
Cap. Flow
+$272M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,121
New
637
Increased
418
Reduced
436
Closed
588
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$208M |
| 2 |
Charles River Laboratories
CRL
|
+$150M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$91.1M |
| 4 |
Keurig Dr Pepper
KDP
|
+$83.8M |
| 5 |
Medtronic
MDT
|
+$83.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$170M |
| 2 |
Boston Scientific
BSX
|
+$145M |
| 3 |
Procter & Gamble
PG
|
+$139M |
| 4 |
EPAM Systems
EPAM
|
+$101M |
| 5 |
Fidelity National Information Services
FIS
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.06% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Financials | 10.11% |
| 4 | Technology | 9.6% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
NetEase
NTES
$82B
| $1.21M | 0.01% |
13,345
-16,235
| -55% | -$1.53M |
|
952
Ameren
AEE
$31.6B
| $1.21M | 0.01% |
15,297
-1,027
| -6% | -$80.6K |
|
953
United Therapeutics
UTHR
$26.2B
| $1.21M | 0.01% |
11,976
-13,661
| -53% | -$1.5M |
|
|
RAVN
954
DELISTED
Raven Industries Inc
RAVN
| $1.21M | 0.01% |
+56,022
| New | +$1.29M |
|
|
CLII.U
955
DELISTED
Climate Change Crisis Real Impact I Acquisition Corporation Units, each consisting of one share of C
CLII.U
| $1.21M | 0.01% |
+120,000
| New | +$1.21M |
|
|
MNTA
956
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.2M | 0.01% |
+22,939
| New | +$950K |
|
|
SPTN
957
DELISTED
SpartanNash
SPTN
| $1.2M | 0.01% |
73,589
-50,706
| -41% | -$1.01M |
|
958
Invesco S&P SmallCap Low Volatility ETF
XSLV
$251M
| $1.2M | 0.01% |
+36,242
| New | +$1.25M |
|
|
SGI
959
Somnigroup International
SGI
$15.3B
| $1.2M | 0.01% |
53,904
-229,028
| -81% | -$4.73M |
|
960
Methanex
MEOH
$4.15B
| $1.2M | 0.01% |
49,210
+14,625
| +42% | +$311K |
|
|
RDUS
961
DELISTED
Radius Health, Inc.
RDUS
| $1.2M | 0.01% |
105,641
-231,693
| -69% | -$2.86M |
|
962
Mattel
MAT
$4.47B
| $1.2M | 0.01% |
102,279
-1,196,761
| -92% | -$13.3M |
|
963
LeMaitre Vascular
LMAT
$2.34B
| $1.19M | 0.01% |
36,699
+12,349
| +51% | +$371K |
|
964
Valley National Bancorp
VLY
$8.04B
| $1.19M | 0.01% |
+173,815
| New | +$1.29M |
|
965
OneSpan
OSPN
$579M
| $1.19M | 0.01% |
56,679
-104,858
| -65% | -$2.59M |
|
966
Establishment Labs
ESTA
$2.78B
| $1.18M | 0.01% |
63,867
-59,502
| -48% | -$1.06M |
|
967
Telefônica Brasil
VIV
$21B
| $1.18M | 0.01% |
+153,585
| New | +$1.39M |
|
968
AudioCodes
AUDC
$249M
| $1.18M | 0.01% |
+36,983
| New | +$1.25M |
|
969
Powell Industries
POWL
$7.41B
| $1.18M | 0.01% |
146,505
-59,916
| -29% | -$531K |
|
970
Grupo Aeroportuario del Pacifico
PAC
$13.2B
| $1.18M | 0.01% |
14,578
-51,955
| -78% | -$3.77M |
|
971
Walker & Dunlop
WD
$1.73B
| $1.17M | 0.01% |
22,086
-35,316
| -62% | -$1.85M |
|
972
Banco Bradesco
BBD
$38.8B
| $1.16M | 0.01% |
409,237
+116,409
| +40% | +$381K |
|
973
Vaxcyte
PCVX
$8.03B
| $1.16M | 0.01% |
+23,453
| New | +$934K |
|
974
GoodRx Holdings
GDRX
$1.06B
| $1.15M | 0.01% |
+20,699
| New | +$1.1M |
|
|
TPTX
975
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.14M | 0.01% |
13,052
| – | – |
|
Similar funds
Marshall Wace's Q3 2020 Portfolio in Review
As of Q3 2020, Marshall Wace held 2,121 positions worth $15.6B, up 9.5% from $14.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q3 2020 filing shows 637 new, 418 increased, 436 reduced and 588 closed positions. Its largest new stake was Keurig Dr Pepper: 2,859,399 shares worth $78.9M. The largest sale was Alibaba, an estimated $170M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q3 2020 buy was Keurig Dr Pepper: 2,859,399 shares worth $78.9M.
- Marshall Wace added most to Alphabet (Google) Class A in Q3 2020, an estimated $208M increase.
- Marshall Wace's biggest Q3 2020 reduction was Alibaba, cutting an estimated $170M.
- Marshall Wace fully exited Procter & Gamble in Q3 2020, selling an estimated $139M.
- Marshall Wace's ten largest holdings make up 17% of its $15.6B portfolio in Q3 2020.
- Marshall Wace opened 637 new positions and closed 588 in Q3 2020.
- Marshall Wace's portfolio value rose 9.5% quarter-over-quarter to $15.6B.
Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.